Jan 13, 2022 / 05:00PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
All right. Good afternoon, everybody. I'm Tycho Peterson in the Life Science Team. It's my pleasure to introduce our next company this afternoon, Pacific Biosciences last, but definitely not least. Just a quick reminder that you can submit questions directly through the website.
And with that, let me turn it over to Christian.
Christian O. Henry - Pacific Biosciences of California, Inc. - President, CEO & Director
Tycho, thank you, and thank you to the whole team at JPMorgan for giving us this opportunity today. And I'd also like to thank all of you that have tuned in for the last, but not least, presentation in the genomics space for the conference. But I'm Christian Henry, I'm the Chief Executive Officer, and I'm going to tell you a little bit about how we've been transforming PacBio. Specifically in today's presentation, I'll talk about some of the exciting new chemistry that we've been working on related to our Omniome acquisition. So I'll share some data for the
Pacific Biosciences of California Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot